Newly Approved Oral Medication Slows Rheumatoid Arthritis Joint Damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis patients who did not respond to methotrexate .
Join the discussion below, or Read more at MediLexicon.
Since: Jan 13
#1 Jan 25, 2013
This could be great information for arthritis people.Thanks for information.
#2 Apr 1, 2013
Wow this is amazing if it really slows down the effects of arthritis. I have read somewhere at depuypinnaclelawsuit. com that there may be some preoblems with hip replacements so this is a new alternative.
Add your comments below
|A stroke took his voice, but he never lost faith (May '09)||5 hr||Dan Kidd||29|
|Trending Now 1 HRS Ago This city has banned smo...||9 hr||cough cough hack OMG||1|
|8 Sleep Mistakes You Can Fix Tonight||10 hr||Maria||2|
|Should Doctors Speculate About the President's ...||11 hr||Humanspirit||15|
|Active older population, better technology may ... (Nov '16)||15 hr||Ryan||2|
|Jimmy Carter: Media 'harder' on Trump than othe...||21 hr||Humanspirit||1|
|Family argument, fight lead to charges||Sun||Just saying||1|
Find what you want!
Search Medicine Forum Now
Copyright © 2017 Topix LLC